GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 204 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q1 2022. The put-call ratio across all filers is 1.05 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $132,000 | +1000.0% | 207,300 | +685.2% | 0.01% | – |
| Q4 2021 | $12,000 | +140.0% | 26,400 | +161.4% | 0.00% | – |
| Q3 2021 | $5,000 | -58.3% | 10,100 | -18.5% | 0.00% | – |
| Q2 2021 | $12,000 | -20.0% | 12,400 | +13.8% | 0.00% | -100.0% |
| Q1 2021 | $15,000 | -65.1% | 10,900 | -86.9% | 0.00% | -50.0% |
| Q3 2020 | $43,000 | -35.8% | 83,000 | +675.7% | 0.00% | -50.0% |
| Q4 2019 | $67,000 | -41.2% | 10,700 | -86.9% | 0.00% | -55.6% |
| Q3 2019 | $114,000 | -58.7% | 81,400 | -23.0% | 0.01% | -47.1% |
| Q4 2018 | $276,000 | +51.6% | 105,700 | +147.0% | 0.02% | +54.5% |
| Q3 2018 | $182,000 | -78.0% | 42,800 | -71.0% | 0.01% | -73.2% |
| Q2 2018 | $828,000 | -38.1% | 147,800 | +433.6% | 0.04% | -38.8% |
| Q1 2018 | $1,338,000 | +35.4% | 27,698 | +10.3% | 0.07% | +63.4% |
| Q4 2017 | $988,000 | +814.8% | 25,105 | -51.7% | 0.04% | +583.3% |
| Q2 2017 | $108,000 | -79.2% | 52,000 | -63.9% | 0.01% | -81.2% |
| Q1 2017 | $518,000 | – | 144,000 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 595,473 | $25,790,000 | 4.19% |
| Grace Capital | 131,549 | $5,697,000 | 3.60% |
| Fernwood Investment Management, LLC | 201,657 | $8,734,000 | 3.44% |
| Fairmount Funds Management LLC | 215,000 | $9,312,000 | 3.33% |
| Arctis Global LLC | 293,700 | $12,720,000 | 2.74% |
| Perceptive Advisors | 5,674,711 | $245,771,000 | 2.64% |
| ArchPoint Investors | 217,510 | $9,420,000 | 2.61% |
| Alerce Investment Management, L.P. | 126,270 | $5,469,000 | 2.15% |
| Profit Investment Management, LLC | 42,196 | $1,826,000 | 1.17% |
| Affinity Asset Advisors, LLC | 50,000 | $2,166,000 | 1.15% |